1783 results for Treatments
Refine Your Search
We Dare to Dream so Their Dreams Come True
Did you know that blood cancer is the most common cancer diagnosis for children, accounting for 40% of pediatric cancer cases? In fact, nearly 55,000 …
The Immune System and Blood Cancer: 4 Things You Need to Know
Immunotherapy uses the power of the immune system to treat blood cancer. Today it is a standard treatment that has a profound effect in some blood can…
New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma
Just one year after the first CAR T-cell treatment was approved for multiple myeloma, the second is about to hit the market. The FDA approved ciltacab…
Choosing a blood cancer specialist or treatment center for young adults
After receiving a blood cancer diagnosis, you will want to find a blood cancer specialist or choose a treatment center. Here’s how.
Support Resources
LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) yesterday approved brentuximab vedotin (Adcetris®) in combination with standard dose-intensive chemotherap…
News Release
Suggested Reading - Eating Well Through Cancer: Easy Recipes & Recommendations During & After Treatment
Eating Well Through Cancer: Easy Recipes & Recommendations During & After Treatment By Holly Clegg, Gerald Miletello Holly Clegg, 2006 261 Pages ISB…
Delivering unique immunotherapeutics for treatment of mantle cell lymphoma
City of Hope has a reputation for innovative translational research, and multiple researchers in the proposed application are prominent in the lymphom…
Development of BET protein bromodomain inhibitors for the treatment of patients with hematologic malignancies
In July 2012, LLS began its partnership with Constellation to support three first-in-human Phase 1 clinical trials for blood cancer patients and the p…
Autologous CD22 CAR T cell Therapy for the Treatment of non-Hodgkin Lymphoma
CD19 targeting chimeric antigen receptor (CAR) T cell therapies (CAR19) are effective treatments for patients with non-Hodgkin Lymphoma (NHL), however…
Highlights from ASCO 2021
The 2021 American Society of Clinical Oncology (ASCO) Annual Meeting took place last week. ASCO brings together the cancer community to explore the la…
Pharmacological inhibition of the transcription factor PU.1 as a novel treatment for acute myeloid leukemia
Transcription factors are components of a cell which control our genetic information and are known to have altered function in diseases such as Acute …
“Stages” of Leukemia: Understanding Classification and Progression
Table of contentsStages of Leukemia Chronic Lymphocytic Leukemia (CLL) Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Chronic Mye…
FDA Approves New Treatment for Children and Young Adults with Chronic Graft versus Host Disease
This week marked another milestone for the treatment of graft versus host disease in children. The U.S. Food and Drug Administration (FDA) approved ib…
News Release
FDA Approves Treatment for Patients Newly Diagnosed with Most Common Lymphoma
“The FDA’s decision gives newly diagnosed patients with this aggressive form of lymphoma their first new treatment option in nearly two decades,” says…
What causes acute myeloid leukemia?
Table of contents: What causes acute myeloid leukemia?What is AML?Role of bone marrow and white blood cellsHow leukemia interferes with blood cell cou…
Early Detection and Intervention in Smoldering Multiple Myeloma: population-based screening and treatment; Edit-SMM
We build on the success from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study, where over 80,000 consented to a nationwide sc…
Understanding AML vs. ALL: Navigating the complex field
Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…
Walgreens helps raise more than $6 million for The Leukemia & Lymphoma Society (LLS) and Susan G. Komen to Advance Cancer Research and Increase Access to Care
Join us in thanking Walgreens stores and customers across the country for raising over $6 million for LLS and Susan G. Komen during their spring campa…
FDA Expands Use of Leukemia Treatment to Include Children
LLS supported the very first antibody-drug conjugate gemtuzumab ozogamicin, which targets CD33, and was approved in 2000 to treat acute myeloid leukem…
News Release
Myelodysplastic Syndromes: Diagnosis, Treatment, and Side Effect Management
This activity is intended for oncology nurse practitioners, nurses, and social workers involved in the care of patients with myelodysplastic syndromes…
Education Resources
Niclosamide for the treatment of relapsed pediatric acute myeloid leukemia
Niclosamide is an FDA approved anti-parasitic drug that is well tolerated in adults and children. AML cells are sensitive to niclosamide, act synergis…